CAR-T cell therapy
A type of immunotherapy that reprograms a patient's own T cells to attack cancer.
What it is
CAR-T cell therapy is a type of treatment that uses a patient's own immune system to fight cancer. It involves taking a sample of the patient's T cells, which are a type of immune cell, and reprogramming them in a laboratory to recognize and attack cancer cells. These reprogrammed T cells are then returned to the patient's body.
How it works
In a CAR-T cell therapy treatment, a patient's T cells are collected and sent to a laboratory where they are genetically modified to produce a special protein called a chimeric antigen receptor (CAR). This CAR allows the T cells to recognize and bind to specific proteins on the surface of cancer cells. Once the modified T cells are returned to the patient's body, they can seek out and attack cancer cells.
Why it matters
CAR-T cell therapy is significant because it offers a new way for some patients to treat certain types of cancer, particularly those that are difficult to treat with other methods. In some cases, CAR-T cell therapy has been shown to be effective in shrinking or eliminating cancer tumors, which can improve a patient's quality of life and potentially extend their life expectancy.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional for guidance on your health.